EDWARDS LIFESCIENCES CORP (EW)

US28176E1082 - Common Stock

85.94  -0.51 (-0.59%)

After market: 85.94 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
5.233B
19.29%		5.382B
2.86%		6.005B
11.56%		6.715B
11.83%
EBITDA
YoY % growth
1.846B
30.88%		1.965B
6.44%		1.9B
-3.30%		2.152B
13.28%		N/A
EBIT
YoY % growth
1.711B
31.30%		1.825B
6.67%		1.755B
-3.85%		1.982B
12.95%		N/A
Operating Margin
32.70%33.91%29.22%29.52%N/A
EPS
YoY % growth
2.23
20.32%		2.48
11.21%		2.51
1.21%		2.84
13.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		0.66
6.88%
Revenue
Q2Q % growth		1.622B
11.13%
EBITDA
Q2Q % growth		506.66M
EBIT
Q2Q % growth		462.79M
7.15%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.64 0.66-0.02-2.52%
Q3 2023
Q2Q % growth		 0.59
-3.28%		0.61-0.02-3.30%
Q2 2023
Q2Q % growth		 0.66
4.76%		0.67-0.01-0.94%
Q1 2023
Q2Q % growth		 0.62
3.33%		0.63-0.01-0.87%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.534B
13.78%		1.54B-5.9M-0.38%
Q3 2023
Q2Q % growth		 1.481B
12.27%		1.523B-42.1M-2.76%
Q2 2023
Q2Q % growth		 1.53B
11.38%		1.549B-18.8M-1.21%
Q1 2023
Q2Q % growth		 1.46B
8.83%		1.435B24.6M1.71%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -3.97% 0.12% -1.55%
Revenue-0.06% 0.25% -0.04% 0.07%